News
The analysts said Sun Pharma and Lupin were their top picks with a large US focus, as well as India-focused companies such as Torrent Pharma, Mankind, Ipca, and Eris Lifesciences. “In case the ...
Divi’s is likely to be the least impacted, they added. BNP Paribas continues to prefer Torrent Pharma and JB Chemicals & Pharmaceuticals in the sector. Nifty Pharma and healthcare ended in the ...
Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on ...
can you still buy into pharma stocks? Lupin Q1 FY25 Results Preview: Net profit likely to grow by one-third, margin may improve by 200 bps; here is what else you can expect Torrent Pharma Q4 Results ...
Companies with high US exposure such as Sun Pharma (32%), Torrent Pharma (10%), Piramal Pharma (41%), Zydus Life Sciences (46%), Gland Pharma (50%), Aurobindo (48%), and Dr. Reddy’s (47%) are at the ...
Apr. 24, 2025 4:01 PM ETAscendis Pharma A/S (ASND) This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of ...
Out of the 20 companies forming part of the National Stock Exchange’s NIFTY pharma index, 18 were in the red on Friday even as the sectoral index closed 4.03% lower. Barring Torrent Pharma and ...
CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...
The Board of Directors of Associated Alcohols and Breweries Limited, at its meeting held today have approved the financial ...
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $180.00. The company’s shares closed ...
Vincerx Pharma (VINC) announced its intention to file a Form 25 Notification of Delisting with the SEC on or about April 28, which will remove Vincerx’s common stock from listing and ...
Pharma stocks crashed 6 per cent before closing 4 per cent lower on Friday after US President Donald Trump reportedly threatened tariffs on pharma products at “levels never seen before.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results